First Quarter Round Up

ktMINE has had a busy first quarter. Here are some highlights from the Q1 vIP Newsletter. Be sure to sign up for our blog updates so you never miss out on important ktMINE updates/happenings. Featured News ktMINE Listed on IRS Announcement and Report Concerning APAs 2018 marks the fourth straight year ktMINE has been listed

Ranking the Largest U.S. University Innovation Portfolios

Prior to attending the AUTM Annual meeting this past February, ktMINE research analysts reviewed the portfolios of U.S. universities and compiled a list of the 20 largest university innovation portfolios. The universities listed below have the largest patent portfolios of granted U.S. patents based on ktMINE data. 20 Largest University Innovation Portfolios 1. University of

Recent Litigation Trends Show Trademark Infringement is a Worldwide Concern

In the world of intellectual property (IP), trademarks are often seen as secondary in value to patents and know-how in a company’s intangible portfolio. However, in some industries brand recognition is paramount to success. Patent infringement often takes center stage in IP legal news, but trademarks see their fair share of litigation activity as well.

U.S. Committee Denies Broadcom Acquisition of Qualcomm Patents

On Monday, President Trump announced that, upon recommendation from the Committee on Foreign Investment in the United States (CFIUS), he would block any potential acquisition of Qualcomm by Broadcom on the grounds of national security. It further states: “The Purchaser and Qualcomm shall immediately and permanently abandon the proposed takeover. Immediately upon completion of all

AUTM Annual Meeting: Creating Relationships, and the Impact of Technology

From Sunday, February 18th through Wednesday, February 21st, Eric Podlogar, ktMINE’s IP Strategy & Valuation Market Lead, and Courtney Conn, ktMINE’s Business Development Consultant, joined over 1,700 attendees at the Annual Association of University Technology Managers (AUTM) Conference in Phoenix, Arizona. The annual meeting brought together over 800 organizations from over 30 countries around the

Licensing Opportunities Abound For CRISPR Gene-Editing Technology

On February 14, the French immunotherapy company Cellectis announced its intentions to license out its recently granted patents for CRISPR technology. The two patents granted to the company by the U.S. Patent and Trademark Office in January and February of this year relate to gene-editing methods in the treatment of cancer. CRISPR, or clustered regularly

Contraception and Fertility in the Digital Age

Last February, the digital contraceptive startup Natural Cycles received EU certification as a legitimate form of contraception. In November, the company received a $30 million investment led by European venture capitalist fund EQT Ventures for further development. The app uses an algorithm that interprets basal body temperature as an indicator of ovulation. Using a thermometer